Sunday 11 October 2026 Export all MRK data to Excel Powerpack

Merck & Co., Inc.

MRK Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS fell 130.7%, free cash flow grew 77.0% and total debt rose 50.4%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for five.

145.60 3.22 +2.26%
Market cap
$351.3B
P/E
116×
Fwd P/E
53.9×
Dividend yield
2.34%
F-score
4/9
Altman Z
3.77
Beneish M
−2.27
Dividend safety
74/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
14.46 14.78 808.86 19.40 14.85 28.18 22.78 31.43 57.69 41.02
Piotroski F-Score
4 9 5 7 8 5 6 8 7 7
Altman Z-Score
3.77 4.11 3.84 4.68 3.38 3.17 3.91 3.73 3.10 3.12
P/S ratio
4.05 3.93 4.78 4.75 3.98 4.76 5.69 4.59 3.65 3.99
P/FCF ratio
21.31 13.92 31.42 19.13 22.35 61.94 40.36 23.38 32.10 18.12
Altman Z″-Score (non-manufacturers)
4.21 4.18 2.80 4.41 3.49 2.53 3.31 3.20 3.19 3.59
Beneish M-Score
(2.27) (2.69) (3.01) (2.62) (2.17) (2.61) (2.70) (2.78) (2.72) (2.76)
P/Operating CF
92.18 73.01 1,167.85 63.52 38.06 57.91 935.26 54.07 36.44 43.71
Dividend Safety Score
74 — — — — — — — — —
P/B ratio
5.00 5.43 7.63 6.11 5.07 7.77 8.56 7.23 4.24 3.94
Price to Tangible BV
59.83 30.22 0.00 61.38 0.00 0.00 0.00 0.00 69.68 32.80
EV/Sales
4.55 4.25 5.22 5.01 4.45 5.17 6.00 4.85 3.97 4.24
EV/EBITDA
10.58 11.03 45.98 13.38 13.19 23.77 20.90 15.25 13.89 15.38
EV/Operating CF
17.94 12.70 24.13 15.55 16.50 28.20 26.44 18.79 24.70 16.26
EV/FCF
23.91 15.07 34.33 20.19 24.96 67.37 42.59 24.70 34.92 19.25
Quick Ratio
0.93 0.84 0.68 0.93 0.73 0.54 0.78 0.72 0.83 1.24
Current Ratio
1.54 1.36 1.25 1.47 1.27 1.02 1.24 1.17 1.33 1.78
Net Debt/EBITDA
1.15 0.84 3.90 0.70 1.38 1.92 1.09 0.81 1.12 0.91
Debt/Assets
34.16% 29.43% 31.58% 26.33% 29.04% 27.69% 26.94% 23.97% 24.30% 25.45%
Debt/Equity
0.89 0.74 0.90 0.62 0.80 1.00 0.87 0.74 0.62 0.60
Asset Turnover
0.51 0.57 0.56 0.55 0.49 0.47 0.47 0.50 0.44 0.40
Operating CF/Net income
0.90 1.25 35.63 1.32 1.01 1.08 0.90 1.76 2.69 2.65
Capex/Depreciation
(0.70) (0.75) (1.00) (1.12) (1.38) (1.27) (1.02) (0.58) (0.40) (0.29)
ROE
36.86% 40.75% 0.87% 34.44% 41.00% 27.50% 37.23% 20.24% 6.39% 9.22%
ROA
14.37% 15.30% 0.34% 13.52% 13.23% 8.03% 11.79% 7.30% 2.61% 3.98%
ROIC
16.28% 18.82% 2.87% 18.55% 13.56% 8.12% 12.94% 14.76% 8.96% 6.84%
Return on Tangible Assets
45.07% 50.14% 1.24% 44.12% 50.83% 40.53% 48.45% 36.67% 12.88% 15.41%
Average Days of Receivables
66.11 58.46 62.84 58.18 69.17 59.81 63.24 61.02 62.53 64.35
Research and Development Expense of Revenue
24.29% 27.95% 50.79% 22.85% 25.14% 32.27% 24.86% 23.06% 25.77% 25.78%
Selling, General and Administrative Expense of Revenue
16.51% 16.86% 17.47% 16.94% 19.78% 21.57% 24.17% 23.89% 25.11% 25.16%
Intangible Assets out of Total Assets
0.35 0.32 0.37 0.38 0.42 0.36 0.40 0.38 0.37 0.37
Share Based Compensation of Revenue
1.26% 1.19% 1.07% 0.91% 0.98% 1.06% 0.99% 0.82% 0.78% 0.75%
Graham Net Nets
(0.15) (0.13) (0.13) (0.10) (0.19) (0.19) (0.14) (0.15) (0.19) (0.15)
Graham Number
58.72 52.66 6.84 48.43 41.90 25.02 29.48 22.95 16.28 21.42
Earnings Yield
6.92% 6.77% 0.12% 5.16% 6.73% 3.55% 4.39% 3.18% 1.73% 2.44%
Free Cash Flow Yield
4.69% 7.18% 3.18% 5.23% 4.47% 1.61% 2.48% 4.28% 3.12% 5.52%
Revenue per Share
25.98 25.34 23.70 23.41 19.25 16.41 15.25 15.88 14.70 14.39
Operating CF per Share
6.58 8.48 5.13 7.54 5.19 3.01 3.46 4.10 2.36 3.75
Capex per Share
(1.64) (1.33) (1.52) (1.73) (1.76) (1.75) (1.31) (0.98) (0.69) (0.58)
Free Cash Flow per Share
4.94 7.15 3.60 5.81 3.43 1.26 2.15 3.12 1.67 3.17
Cash per Share
5.82 5.41 2.80 5.21 3.20 3.18 4.07 3.33 3.11 5.18
Shareholders Equity per Share
21.05 18.31 14.83 18.19 15.12 10.04 10.14 10.09 12.66 14.57
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
21.05 18.31 14.83 18.19 15.12 10.04 10.14 10.09 12.66 14.57
Free Cash Flow
12,360.00 18,096.00 9,143.00 14,707.00 8,674.00 3,188.00 5,515.00 8,307.00 4,563.00 8,762.00
Working Capital
15,189.00 10,362.00 6,474.00 11,483.00 6,394.00 437.00 5,263.00 3,669.00 6,152.00 13,410.00
Capital Expenditures
(4,112.00) (3,372.00) (3,863.00) (4,388.00) (4,448.00) (4,429.00) (3,369.00) (2,615.00) (1,888.00) (1,614.00)
Net Current Asset Value
(40,688.00) (31,952.00) (36,872.00) (27,380.00) (37,171.00) (38,420.00) (30,913.00) (29,880.00) (28,537.00) (24,455.00)
EV/EBIT
13.37 13.48 106.26 16.24 16.40 38.71 29.63 22.97 23.44 30.68
Capex to Sales
0.06 0.05 0.06 0.07 0.09 0.11 0.09 0.06 0.05 0.04
Price to Operating Income
11.91 12.46 97.25 15.39 14.69 35.59 28.08 21.75 21.55 28.87
Other line items
Depreciation/Fixed assets
0.23 0.19 0.17 0.18 0.17 0.21 0.22 0.34 0.38 0.45
Cash ROIC
10.84% 19.14% 11.66% 16.71% 11.26% 5.42% 9.32% 14.95% 7.08% 11.10%
Accounts Receivable Turnover
5.90 6.22 6.07 6.35 6.08 6.11 5.65 6.07 5.78 5.90
Accounts Payable Turnover
3.86 3.80 3.94 3.92 3.05 3.38 3.41 4.21 4.37 5.25
Inventory Turnover
2.57 2.44 2.63 2.94 2.37 2.36 2.10 2.56 2.59 2.93
Average Days of Payables
98.12 97.99 88.77 89.39 123.46 115.98 113.55 89.65 87.69 73.03
Days of Inventory on Hand
148.34 146.76 143.91 123.92 159.46 148.86 181.59 146.98 144.06 126.59
Average Receivables
11,026.50 10,313.50 9,899.50 9,340.00 8,016.50 6,790.50 6,924.50 6,972.00 6,945.50 6,751.00
Average Payables
4,241.50 4,000.50 4,093.00 4,436.50 4,468.00 4,032.50 3,528.00 3,210.00 2,954.50 2,670.00
Average Inventory
6,383.50 6,233.50 6,134.50 5,932.00 5,753.50 5,766.00 5,709.00 5,268.00 4,981.00 4,783.00
Average Assets
126,986.00 111,890.50 107,917.50 107,427.00 98,641.00 87,992.50 83,517.00 85,254.50 91,624.50 98,527.00
Average Common Equity
49,517.00 42,003.50 41,846.50 42,157.50 31,830.50 25,702.50 26,441.50 30,725.50 37,438.50 42,537.50

Fold the line items

Columns are period end dates